Optometrics Corporation Achieves ISO 9001:2008 Certification

  Optometrics Corporation Achieves ISO 9001:2008 Certification

             Compliance Reflects Commitment to Quality Management

Business Wire

WATERTOWN, Mass. -- November 16, 2012

Dynasil Corporation of America (NASDAQ: DYSL) today announced that its
Optometrics Corporation subsidiary of Ayer, Massachusetts has become ISO
9001:2008 certified. Optometrics is a worldwide supplier of high quality
optical components including gratings, lenses, filters, laser optics,
monochromators, and specialized optical systems and software.

Achieving ISO 9001:2008 certification indicates that premium Quality
Management practices are adhered to and a systematic approach to quality
testing and processes is taken to ensure consistent customer satisfaction.
This independent certification validates Optometrics’ commitment to quality
and affirms that Optometrics has thoroughly documented its quality processes
while meeting the stringent qualifications for the global ISO 9001:2008
standard. Over a million organizations worldwide are independently certified,
making ISO 9001 one of the most widely used management tools in the world
today.

“This is an important milestone for Optometrics and Dynasil,” said Peter
Sulick, Dynasil’s Chairman of the Board, Interim Chief Executive Officer and
President. “Our customers rely on us for quality products and service and this
certification demonstrates our rigorous quality standards and commitment to
continually improving our business processes. Customers can be confident that
we have a systematic approach for achieving customer satisfaction that
delivers results.”

“The ISO 9001:2008 certification, along with the recently acquired CE Mark for
Optometrics’ SPF unit, illustrates our commitment to quality and service,”
said Laura Lunardo, Optometrics’ COO. “Optometrics has always had a strict
quality assurance program. The additional structure of the ISO 9001
registration has helped us define and clarify our organizational quality
processes to better serve our customers throughout the world. These processes
represent a set of principles that ensure a common-sense approach to managing
business activities that builds upon our experience of more than four decades
of service to our customers.”

About Dynasil

Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures
detection and analysis technology, precision instruments and optical
components for the homeland security, medical and industrial markets.
Combining world-class technology with expertise in research and materials
science, Dynasil is commercializing products including dual-mode radiation
detection solutions for Homeland Security and commercial applications, probes
for medical imaging and sensors for non-destructive testing. Dynasil has an
impressive and growing portfolio of issued and pending U.S. patents. The
Company is based in Watertown, Massachusetts, with additional operations in
Mass., Minn., NY, NJ and the United Kingdom. More information about the
Company is available at www.dynasil.com.

Forward-looking Statements

This news release may contain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These forward-looking
statements regarding future events and our future results are based on current
expectations, estimates, forecasts, and projections and the beliefs and
assumptions of our management. These forward-looking statements may be
identified by the use of words such as “may,” “could,” “expect,” “estimate,”
“anticipate,” “continue” or similar terms, though not all forward-looking
statements contain such words. The actual results of the future events
described in such forward-looking statements could differ materially from
those stated in such forward-looking statements due to a number of important
factors. These factors that could cause actual results to differ from those
anticipated or predicted include, without limitation, our ability to develop
and commercialize our products, including our dual mode detectors and the
development of new technologies including at Dynasil Biomedical, the size and
growth of the potential markets for our products and our ability to serve
those markets, the rate and degree of market acceptance of any of our
products, general economic conditions, costs and availability of raw materials
and management information systems, our ability to obtain and maintain
intellectual property protection for our products, competition, the loss of
key management personnel, litigation, the effect of governmental regulatory
developments, the availability of financing sources, our ability to identify
and execute on acquisition opportunities and integrate such acquisitions into
our business, and seasonality, as well as the uncertainties set forth in the
Company’s Annual Report on Form 10-K and from time to time in the Company's
other filings with the Securities and Exchange Commission. The Company
disclaims any intention or obligation to update any forward-looking
statements, whether as a result of new information, future events or
otherwise.

Contact:

Dynasil Corporation of America
Patty Kehe, 617-668-6855
pkehe@dynasil.com
or
Sharon Merrill
David Calusdian
Executive Vice President and Partner
617-542-5300
DYSL@InvestorRelations.com